Viral weight loss drug linked to pancreatitis Semaglutide could be putting patients at greater risk of severe gastrointestinal complications when used for obesity management.
Diabetes policies should reflect GPs’ ‘central role’: RACGP The college has put forward 17 recommendations which it says ‘would greatly contribute’ to better diabetes care.
Wastewater confirms high level of antimicrobial resistance in aged care More than 90 resistant E. coli isolates were identified from just three facilities, suggesting concerning rates among one of Australia’s most vulnerable groups.
Long COVID plagued by ‘confusion and undereducation’ Patients are ‘falling through the cracks’ due to a lack of treatment, according to researchers calling for a diagnosis overhaul.
PBS lists once-a-day pill for chronic psoriasis While GPs cannot initiate treatment with the medication, they still have a clear role in identifying eligible patients.
Does menstruation play a part in diabetes diagnosis? Researchers have suggested lowering HbA1c cut-offs for premenopausal women, but Australian GPs say more investigation is needed.
Injections ‘no better than placebo’ for hand osteoarthritis: Study The most effective interventions are oral NSAIDs and glucocorticoids, according to the results of a systemic review published this week.
Molnupiravir linked to COVID mutations Researchers found the widely used antiviral could be driving new SARS-CoV-2 variants, but there is no evidence these pose any additional threat.
Do not initiate new patients on semaglutide: TGA The medication is again in short supply due to off-label prescribing for weight loss, despite only being approved for type 2 diabetes management.
Time to consider a skeletal muscle relaxant? SPONSORED: Orphenadrine has been shown to be effective on painful muscle spasm, in comparison to placebo.